甲氨蝶呤单药用于诱导和维持溃疡性结肠炎临床缓解：出师未捷。 - Suppr | 超能文献

Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.

作者信息

Dulai Parambir S

机构信息

Division of Gastroenterology, University of California at San Diego, La Jolla, California.

出版信息

Gastroenterology. 2018 Oct;155(4):967-969. doi: 10.1053/j.gastro.2018.09.007. Epub 2018 Sep 8.

DOI:10.1053/j.gastro.2018.09.007

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.甲氨蝶呤单药用于诱导和维持溃疡性结肠炎临床缓解：出师未捷。

Gastroenterology. 2018 Oct;155(4):967-969. doi: 10.1053/j.gastro.2018.09.007. Epub 2018 Sep 8.

2

Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?区分克罗恩病和溃疡性结肠炎在治疗上总是很重要吗？

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S202-3. doi: 10.1002/ibd.20729.

3

Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.美沙拉嗪每日一次与每日多次疗法治疗轻至中度溃疡性结肠炎的荟萃分析

Colorectal Dis. 2016 Jul;18(7):O214-23. doi: 10.1111/codi.13393.

4

A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.关于左侧溃疡性结肠炎和溃疡性直肠炎治疗方案的文献荟萃分析与综述。

Am J Gastroenterol. 2000 May;95(5):1263-76. doi: 10.1111/j.1572-0241.2000.01940.x.

5

Mesalamine with MMX technology for the treatment of ulcerative colitis.采用MMX技术的美沙拉嗪用于治疗溃疡性结肠炎。

Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):299-314. doi: 10.1586/17474124.2.3.299.

6

Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.每日一次或两次的MMX美沙拉嗪（SPD476）诱导轻度至中度活动性溃疡性结肠炎缓解的效果。

Clin Gastroenterol Hepatol. 2007 Jan;5(1):95-102. doi: 10.1016/j.cgh.2006.10.025.

7

Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.每日一次美沙拉嗪制剂用于维持溃疡性结肠炎缓解：一项随机、安慰剂对照临床试验

J Clin Gastroenterol. 2016 Apr;50(4):318-25. doi: 10.1097/MCG.0000000000000414.

8

The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.用6-巯基嘌呤治疗溃疡性结肠炎的长期结果。

Am J Gastroenterol. 1996 Sep;91(9):1711-4.

9

Extended-release mesalamine granules for ulcerative colitis.用于溃疡性结肠炎的缓释型美沙拉嗪颗粒。

Ann Pharmacother. 2012 Nov;46(11):1529-36. doi: 10.1345/aph.1R171. Epub 2012 Oct 31.

10

Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis.

Inflamm Bowel Dis. 2006 Jul;12(7):537-42. doi: 10.1097/01.ibd.0000225345.29603.7d.

引用本文的文献

1

Methotrexate in inflammatory bowel disease: A primer for gastroenterologists.甲氨蝶呤在炎症性肠病中的应用：胃肠病学家指南。

Saudi J Gastroenterol. 2022 Jul-Aug;28(4):250-260. doi: 10.4103/sjg.sjg_496_21.

2

Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients.功能分子网络分析有助于预测抗TNF难治性IBD患者对维得利珠单抗治疗的反应。

Crohns Colitis 360. 2020 Apr;2(2):otaa037. doi: 10.1093/crocol/otaa037. Epub 2020 May 24.